CASE STUDY: RESPIRATORY TREATMENT

Optimizing Non-Ophthalmic Phase 3 Trials with Point-of-Need Eye Assessments

THE CHALLENGE

During the chronic cough study, mandated by the FDA, Company W had to incorporate an ocular substudy to monitor eye health. The primary issue was that the selected study sites, specializing in respiratory treatments, lacked the resources for ocular assessments. This led to challenges, including pushback from the sites and difficulties in coordinating with local ophthalmologists.

20/20 ONSITE SOLUTION

Company W offered two options to the study sites: collaborate with local ocular specialists or opt-in to use 20/20 Onsite's mobile vision services. The latter option included a custom onboarding for sites into 20/20 Onsite's program, fostering a seamless relationship to support the trial's ocular substudy.

IMPLEMENTING POINT-OF-NEED SOLUTIONS

ONBOARDING AND RELATIONSHIP BUILDING:
20/20 Onsite onboarded the sites into their program, establishing strong relationships with key personnel at each site to ensure smooth operations.

REDUCING FRICTION:
Regular check-ins and oversight were conducted to ensure sites felt supported. This was crucial as many sites were not initially prepared to handle the additional workload of the ocular substudy.

ADDRESSING CHALLENGES:
Some sites faced difficulties with scheduling conflicts and patient travel requirements. Even worse, a surprising number of sites did not have a local option. 20/20 Onsite alleviated these issues by managing all scheduling aspects, ensuring patients were seen within the protocol's window.

mobile vision clinic on the side of the road

RESULTS

ENHANCED EFFICIENCY AND SATISFACTION

SITE FEEDBACK:

During investigator meetings, sites praised 20/20 Onsite for simplifying scheduling and reducing the administrative burden.

DOCUMENTATION CONSISTENCY:

Sites using 20/20 Onsite ophthalmology staff experienced fewer queries on source documentation due to consistent training and procedures.

DATA INTERPRETATION:

A higher query rate can occur when non-ophthalmology staff are required to read and interpret ophthalmic data. Our experienced staff removed this risk.

INCREASED PARTICIPATION AND SUCCESS RATES

INCREASED PARTICIPATION:

Post-investigator meeting, 8 additional sites adopted 20/20 Onsite's services, driven by positive feedback and observed success.

IMPROVED SCREENING RATES:

Sites utilizing 20/20 Onsite not only excelled in the ocular substudy but were also able to screen subjects for the main study.

Our Track Record

97%

Participants Recommended

States with Patients

100%

Screening Timelines Met

FINAL ASSESSMENT

The integration of 20/20 Onsite's mobile vision services significantly improved the operational efficiency and success of Company W's chronic cough study. By addressing logistical challenges and ensuring consistency in documentation, Company W could focus on their primary research goals, ultimately contributing to the study's success.

For more information or to discuss how 20/20 Onsite can support your non-ophthalmic and ophthalmic clinical trials schedule a consultation and explore our point-of-need solutions.

Schedule a Consultation

View More Case Studies

Streamlining Phase 1 Trials with the Mobile Vision Pod

Read

Expanding Access to Post-Market Safety Exams with Point-of-Need Care

Read

Enhancing Phase 1 Clinical Trials with Point-of-Need Safety Assessments

Read